The Cost-effectiveness of Artificial Intelligence Acute Kidney Injury Prediction Auxiliary Software (Acura AKI)
Huede Healthtech Co., Ltd.
3,600 participants
Oct 17, 2024
INTERVENTIONAL
Conditions
Summary
"Huede" AI Aided AKI Prediction Software, Acura AKI, uses machine learning algorithms to predict the risk of AKI within the next 24 hours and provide a ranking of feature importance. By using Acura AKI, physicians can assess the risk of AKI, focusing on high-risk patients to provide care decisions. This study will be conducted in a prospective randomized clinical trial in adult ICUs, implementing the Acura AKI system for predicting AKI. The study aims to determine whether early prediction and intervention using the Acura AKI system can improve the outcomes of critically ill patients with adverse kidney conditions. The study endpoint is to evaluate the cost-effectiveness of using Acura AKI, including the incidence of AKI, dialysis rates, mortality rates, length of hospital stay, and treatment costs.
Eligibility
Inclusion Criteria3
- Over 20 years old
- Admitted to adult ICU
- Hospital stay of more than 30 hours
Exclusion Criteria7
- Known to have acute kidney injury at enrollment
- Currently undergoing hemodialysis treatment
- No available blood or urine test data
- Pregnant women
- HIV-positive patients
- Those who have not provided informed consent form
- Regarded as unsuitable for inclusion in the trial by the researcher
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
When the AI algorithm (Acura AKI) identifies a high-risk AKI patient, nephrologists and ICU pharmacists will receive an alert message. Upon receiving the alert, they will review the patient's electronic health record and make treatment suggestions based on AKI bundle care protocols. They will also coordinate with the patient's primary care team to ensure that the recommendations are implemented
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06685367